Literature DB >> 18060747

Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.

Daniela A Quinteros1, Verónica Ramirez Rigo, Alvaro F Jimenez Kairuz, María E Olivera, Ruben H Manzo, Daniel A Allemandi.   

Abstract

The interaction between a cationic polymethacrylate (Eudragit E, EU) and a set of 7 drugs having acid groups (AH) was studied. Two series of complexes were prepared (EU-AH50 and EU-AH50Cl50), in both 50% of the basic groups of EU were neutralized with AH but in the second, the remaining groups were further neutralized with HCl. These products were stable solid ionic complexes that were characterized through infrared spectroscopy and X-ray power diffraction. All EU-AH50Cl50 at 5-10mg/ml produced clear optically isotropic aqueous dispersions. This result was in line with the increase of the apparent solubility of the low solubility AH assayed. The species distribution, as determined on the complex of diclofenac, showed a degree of counterion condensation as high as 97.9%. The reversibility of the counterion condensation, as well as the affinity between EU and AH, was evaluated through the proton withdrawing effect produced by the ionic exchange generated by titration with NaCl. Besides, drug delivery in bicompartimental Franz cells towards water as receptor medium was very slow. However, it was increased as water was replaced by NaCl solution that upon diffusion generates ionic exchange. Therefore, the EU-AH system behaves as a reservoir of drug able to deliver it in simulated biological fluid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060747     DOI: 10.1016/j.ejps.2007.10.002

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

Review 1.  Novel platforms for oral drug delivery.

Authors:  P Colombo; F Sonvico; G Colombo; R Bettini
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

2.  Ciprofloxacin-lidocaine-based hydrogel: development, characterization, and in vivo evaluation in a second-degree burn model.

Authors:  María Florencia Sanchez; Susana Andrea Breda; Elio Andrés Soria; Luis Ignacio Tártara; Rubén Hilario Manzo; María Eugenia Olivera
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.

Authors:  Taro Kojima; Kenjirou Higashi; Toyofumi Suzuki; Kazuo Tomono; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2012-01-05       Impact factor: 4.200

4.  Zwitterionic chitosan derivatives for pH-sensitive stealth coating.

Authors:  Peisheng Xu; Gaurav Bajaj; Tyler Shugg; William G Van Alstine; Yoon Yeo
Journal:  Biomacromolecules       Date:  2010-09-13       Impact factor: 6.988

5.  Cationic polymer contributes to broaden the spectrum of vancomycin activity achieving eradication of Pseudomonas aeruginosa.

Authors:  Melisa B Corti; Luciana P Campagno; Verónica L Romero; Silvina Gutierrez; Fabiana L Alovero
Journal:  Arch Microbiol       Date:  2022-07-20       Impact factor: 2.667

6.  A ciprofloxacin extended release tablet based on swellable drug polyelectrolyte matrices.

Authors:  José M Bermúdez; Alvaro F Jimenez-Kairuz; Maria E Olivera; Daniel A Allemandi; Ruben H Manzo
Journal:  AAPS PharmSciTech       Date:  2008-08-07       Impact factor: 3.246

7.  Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Roshan V Tiwari; Joseph T Morott; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Jun-Bom Park; Feng Zhang; Michael A Repka
Journal:  Curr Drug Deliv       Date:  2016       Impact factor: 2.565

8.  Equilibrium and release properties of aqueous dispersions of non-steroidal anti-inflammatory drugs complexed with polyelectrolyte eudragit e 100.

Authors:  Daniela Alejandra Quinteros; Daniel Alberto Allemandi; Ruben Hilario Manzo
Journal:  Sci Pharm       Date:  2012-04-30

9.  Optimized furosemide taste masked orally disintegrating tablets.

Authors:  Mohamed Abbas Ibrahim; Amal El Sayeh F Abou El Ela
Journal:  Saudi Pharm J       Date:  2017-04-13       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.